NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million Nov 3, 2017 03:44AM
NeuroVive Pharmaceutical: NeuroVive Completes Share Issue Raising SEK 70 Million for the Preparation of CicloMulsion®’s Clinical Trial in the US and Commercialization in Europe May 8, 2015 02:33AM